# Excimer Laser Combined With DCB Compared With Angioplasty Alone in the Treatment of Infrapopliteal Lesions.

Study · id `cardio:ct-nct04365075` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04365075](<https://clinicaltrials.gov/study/NCT04365075>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04365075

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 184 participants.

## Technical summary

Registry record NCT04365075. Randomized; no masking; primary purpose treatment. Start 2019-01-01 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 184 participants (planned count; ClinicalTrials.gov record NCT04365075, source copy `cardio:ctgov-nct04365075-2022-10-12`, retrieved 2026-10-31)
- Started: 2019-01-01 (actual) (ClinicalTrials.gov record NCT04365075, source copy `cardio:ctgov-nct04365075-2022-10-12`, retrieved 2026-10-31)
- Primary completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT04365075, source copy `cardio:ctgov-nct04365075-2022-10-12`, retrieved 2026-10-31)
- Completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT04365075, source copy `cardio:ctgov-nct04365075-2022-10-12`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT04365075, source copy `cardio:ctgov-nct04365075-2022-10-12`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04365075-2022-10-12`, retrieved 2026-10-31)

## The registry's words

- Brief title: Excimer Laser Combined With DCB Compared With Angioplasty Alone in the Treatment of Infrapopliteal Lesions.
- Condition: Critical Limb Ischemia
- Condition: Infrapopliteal Lesions
- Intervention (Device): Excimer Laser Combined with DCB
- Intervention (Device): Angioplasty Alone
- Lead sponsor: Xuanwu Hospital, Beijing
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Xuanwu Hospital, Beijing (`cardio:org-xuanwu-hospital-beijing`)

## Provenance

Content hash: a089e4358d8d0e0d6fb870e0b4d50e2cf32af916b8c37c0fad43650babd1a5b9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
